Continuous Quality Improvement for Diabetes

Continuous Quality Improvement for Diabetes: Unique Care Delivery Design's Effect on Quality of Care and Utilization of Resources

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00838825

Enrollment

Registered

2009-02-06

Start date

2005-04-30

Completion date

2011-04-30

Last updated

2016-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

diabetes, chronic care management, resource utilization, outcome, glycohemoglobin, hospitalization

Brief summary

The purpose of this study is to compare health care delivery outcomes and costs achieved by two different approaches to health care delivery. The investigators will compare health outcomes for groups of adult patents with diabetes. One group will be managed by our traditional approach to diabetes care. The second group's care delivery is structured according to a design consistent with the Chronic Care Model (CCM).

Detailed description

The study is comparing the effect of an intervention targeting a subset of the diabetic patients within a primary care practice on the resource utilization of resources and disease outcomes on the entire population of patients with diabetes in that practice. The effect will also be compared across the entire panel of patients assigned to the physicians in the 2 arms of the study.

Interventions

OTHERintroduction of the chronic care model

The care management team is organized according to the chronic care model for health care delivery. They are supported by an information registry for diabetes, receive instruction in self-management, have redesigned their work flow to include delegation of functions to care managers who follow specific guidelines and protocols for managing diabetes

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

30 Years to No maximum

Healthy volunteers

Inclusion criteria

* Primary care physicians practicing in a designated site with \> 200 patients assigned to their panel who have been diagnosed with diabetes

Exclusion criteria

* Refusal to give informed consent

Design outcomes

Primary

Measure	Time frame
resource utilization	baseline compared to 2 years intervention

Secondary

Measure	Time frame
compliance with process measures	3 years
metabolic outcome	3 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026